150 related articles for article (PubMed ID: 16807424)
1. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
DeCarolis DD
N Engl J Med; 2006 Jun; 354(26):2830; author reply 2831-2. PubMed ID: 16807424
[No Abstract] [Full Text] [Related]
2. Enoxaparin versus unfractionated heparin in ST-elevation myocardial infarction.
Sleight P; Eikelboom JW; Bassand JP
N Engl J Med; 2006 Jun; 354(26):2830-1; author reply 2831-2. PubMed ID: 16810777
[No Abstract] [Full Text] [Related]
3. Predictors of initial nontherapeutic anticoagulation with unfractionated heparin in ST-segment elevation myocardial infarction.
Cheng S; Morrow DA; Sloan S; Antman EM; Sabatine MS
Circulation; 2009 Mar; 119(9):1195-202. PubMed ID: 19237657
[TBL] [Abstract][Full Text] [Related]
4. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
Antman EM; Morrow DA; McCabe CH; Murphy SA; Ruda M; Sadowski Z; Budaj A; López-Sendón JL; Guneri S; Jiang F; White HD; Fox KA; Braunwald E;
N Engl J Med; 2006 Apr; 354(14):1477-88. PubMed ID: 16537665
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.
Nammas W; Hossam K
Am Heart J; 2010 Aug; 160(2):e13; author reply e15-6. PubMed ID: 20691818
[No Abstract] [Full Text] [Related]
6. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
[TBL] [Abstract][Full Text] [Related]
7. Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents.
Anusionwu OF; Shah N
Am Heart J; 2010 Sep; 160(3):e25; author reply e27. PubMed ID: 20826240
[No Abstract] [Full Text] [Related]
8. Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
Lopes RD; Alexander KP; Marcucci G; White HD; Spinler S; Col J; Aylward PE; Califf RM; Mahaffey KW
Eur Heart J; 2008 Aug; 29(15):1827-33. PubMed ID: 18519426
[TBL] [Abstract][Full Text] [Related]
9. An unusual case of massive subcutaneous chest wall haemorrhage with enoxaparin.
Rahman MS; Soo L; Qasim A
Acute Card Care; 2011 Sep; 13(3):199-201. PubMed ID: 21877880
[TBL] [Abstract][Full Text] [Related]
10. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
Montalescot G; White HD; Gallo R; Cohen M; Steg PG; Aylward PE; Bode C; Chiariello M; King SB; Harrington RA; Desmet WJ; Macaya C; Steinhubl SR;
N Engl J Med; 2006 Sep; 355(10):1006-17. PubMed ID: 16957147
[TBL] [Abstract][Full Text] [Related]
11. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
[TBL] [Abstract][Full Text] [Related]
12. Enoxaparin in elective percutaneous coronary intervention.
Karthikeyan G
N Engl J Med; 2006 Dec; 355(26):2789; author reply 2790-1. PubMed ID: 17195310
[No Abstract] [Full Text] [Related]
13. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
Baird SH; Menown IB; Mcbride SJ; Trouton TG; Wilson C
Eur Heart J; 2002 Apr; 23(8):627-32. PubMed ID: 11969277
[TBL] [Abstract][Full Text] [Related]
14. Use of anticoagulants in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention: a potential role for enoxaparin.
Christy GW
J Invasive Cardiol; 2008 Nov; 20(11):615-21. PubMed ID: 18987403
[TBL] [Abstract][Full Text] [Related]
15. Regarding "Anticoagulation with enoxaparin versus intravenous unfractionated heparin in postoperative vascular surgery patients".
Paramo JC; Sendzischew H; Sivina M
J Vasc Surg; 2003 Mar; 37(3):700-1; author reply 701. PubMed ID: 12618719
[No Abstract] [Full Text] [Related]
16. Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials.
Mehta SR; Boden WE; Eikelboom JW; Flather M; Steg PG; Avezum A; Afzal R; Piegas LS; Faxon DP; Widimsky P; Budaj A; Chrolavicius S; Rupprecht HJ; Jolly S; Granger CB; Fox KA; Bassand JP; Yusuf S;
Circulation; 2008 Nov; 118(20):2038-46. PubMed ID: 18955665
[TBL] [Abstract][Full Text] [Related]
17. Are activated clotting times helpful in the management of anticoagulation with subcutaneous low-molecular-weight heparin?
Henry TD; Satran D; Knox LL; Iacarella CL; Laxson DD; Antman EM
Am Heart J; 2001 Oct; 142(4):590-3. PubMed ID: 11579347
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Stellbrink C; Nixdorff U; Hofmann T; Lehmacher W; Daniel WG; Hanrath P; Geller C; Mügge A; Sehnert W; Schmidt-Lucke C; Schmidt-Lucke JA;
Circulation; 2004 Mar; 109(8):997-1003. PubMed ID: 14967716
[TBL] [Abstract][Full Text] [Related]
19. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease.
Kleber FX; Witt C; Vogel G; Koppenhagen K; Schomaker U; Flosbach CW;
Am Heart J; 2003 Apr; 145(4):614-21. PubMed ID: 12679756
[TBL] [Abstract][Full Text] [Related]
20. TIMI risk index and the benefit of enoxaparin in patients with ST-elevation myocardial infarction.
Ruff CT; Wiviott SD; Morrow DA; Mohanavelu S; Murphy SA; Antman EM; Braunwald E;
Am J Med; 2007 Nov; 120(11):993-8. PubMed ID: 17976428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]